Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease.
Kotanko
Peter
P
Carter
Mary
M
Levin
Nathan W
NW
D000818:Animals; D001419:Bacteria / Q000187:drug effects; D018407:Bacterial Physiological Phenomena; D018988:Bacterial Translocation; D002908:Chronic Disease; D016207:Cytokines / Q000502:physiology; D004232:Diuretics / Q000627:therapeutic use; D005285:Fermentation; D006801:Humans; D007249:Inflammation / Q000209:etiology*; D007408:Intestinal Absorption; D007422:Intestines / Q000382:microbiology*; D007501:Iron / Q000009:adverse effects / Q000378:metabolism; D007502:Iron Chelating Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000150:complications* / Q000382:microbiology; D019936:Probiotics / Q000627:therapeutic use; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D014511:Uremia / Q000150:complications / Q000382:microbiology / Q000503:physiopathology; D014969:Xanthine Oxidase / Q000378:metabolism
D016207:Cytokines; D004232:Diuretics; D007502:Iron Chelating Agents; D017382:Reactive Oxygen Species; D007501:Iron; D014969:Xanthine Oxidase